Halozyme Therapeutics Inc (NASDAQ:HALO)

22.58
Delayed Data
As of Jun 30
 +1.34 / +6.31%
Today’s Change
7.51
Today|||52-Week Range
22.85
+133.99%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 21.00, with a high estimate of 26.00 and a low estimate of 7.00. The median estimate represents a -7.00% decrease from the last price of 22.58.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$21.8M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.78%
 
 
 
 
 
 
Growthannually 12.57%
 
 
 
 
 
 

Sales

Growthquarterly 16.63%
 
 
 
 
 
 
Growthannually 22.15%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account